Ficha del valor · trimestre archivado
GLUE
Monte Rosa Therapeutics, Inc. · Healthcare · Biotechnology
18Tenedores rastreados
+2Δ titulares
20.02MAcciones mantenidas
$148.32MValor declarado
+2Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +12.5% ·
flujo de acciones -6.0% ·
nuevas posiciones netas +11.1%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | -3 | 40.75M | $985.52M | +5 | −8 |
| Q1 2026 | 84 | +11 | 37.29M | $613.27M | +14 | −3 |
| Q4 2025 | 73 | -1 | 26.21M | $411.01M | +1 | −2 |
| Q3 2025 | 18 | +2 | 20.02M | $148.32M | +2 | — |
| Q2 2025 | 13 | +1 | 20.51M | $92.50M | +1 | — |
| Q1 2025 | 9 | -3 | 9.96M | $46.20M | +1 | −4 |
| Q4 2024 | 12 | +2 | 11.82M | $82.01M | +2 | — |
| Q3 2024 | 9 | +2 | 9.48M | $50.23M | +2 | — |
| Q2 2024 | 7 | — | 8.29M | $30.99M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 4.64M | -26.7% | $34.36M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 4.64M | -26.7% | $34.36M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 3.82M | -0.8% | $28.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (pasivo) | 2.99M | -4.8% | $22.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasivo) | 2.99M | -4.8% | $22.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasivo) | 2.99M | -4.8% | $22.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 2.81M | +22.9% | $20.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.81M | +22.9% | $20.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 2.81M | +22.9% | $20.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Geode Capital Management ✦ (pasivo) | 1.15M | +2.4% | $8.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasivo) | 1.15M | +2.4% | $8.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Marshall Wace ✦ | 902.83K | +102.4% | $6.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Marshall Wace ✦ | 902.83K | +102.4% | $6.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Marshall Wace ✦ | 902.83K | +102.4% | $6.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (pasivo) | 846.77K | +1.8% | $6.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 717.26K | -44.1% | $5.31M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 645.20K | — | $4.78M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Millennium Management ✦ | 444.94K | +588.4% | $3.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 395.73K | -35.7% | $2.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 161.48K | -32.7% | $1.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 158.52K | -29.5% | $1.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | Wellington Management ✦ | 158.52K | -29.5% | $1.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | Wellington Management ✦ | 158.52K | -29.5% | $1.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 101.14K | — | $749,477 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Goldman Sachs Group ✦ | 101.14K | — | $749,477 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Point72 Asset Management ✦ | 90.42K | Nuevo | $670,005 | 0.0% | New | 1 | SEC ↗ |
| 44 | Citadel Advisors ✦ | 51.01K | -34.5% | $377,976 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | Citadel Advisors ✦ | 51.01K | -34.5% | $377,976 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 46 | D. E. Shaw & Co. ✦ | 50.21K | Nuevo | $372,078 | 0.0% | New | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 45.88K | — | $339,956 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $670,005 | 0.0% |
| D. E. Shaw & Co. | $372,078 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 188 tenedores, 86.88M acciones, $1.31B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API